On this episode of the Artificial Intelligence in Drug Discovery podcast, I speak with Regina Barzilay of MIT’s Machine Learning for Pharmaceutical Discovery and Synthesis consortium. Regina is a prolific researcher with many highly cited papers in machine learning, particularly natural language processing, oncology, and chemistry.
Listen now to learn what drove the need for the consortium, the importance of standards and benchmarks for AI drug discovery research, and the progress researchers are making in applying machine learning to chemical synthesis:
PS: In the interview, Regina talks about a video on machine learning in pharma. Here’s the video on YouTube.